Activation PDGFR-α/AKT Mediated Signaling Pathways in Oral Squamous Cell Carcinoma by Mesenchymal Stem/Stromal Cells Promotes Anti-apoptosis and Decreased Sensitivity to Cisplatin

Desmoplasia, a hallmark of a head and neck cancer, has both biologic and physiologic effects on cancer progression and chemotherapeutic response. Mesenchymal stem/stromal cells (MSCs), also known as mesenchymal stromal progenitor cells, have been shown to play a role in cancer progression, alter apo...

Full description

Bibliographic Details
Main Authors: Jia Wang, Ruwen Cui, Cecila G. Clement, Ranjana Nawgiri, Don W. Powell, Irina V. Pinchuk, Tammara L. Watts
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00552/full
_version_ 1818537356079136768
author Jia Wang
Ruwen Cui
Cecila G. Clement
Ranjana Nawgiri
Don W. Powell
Irina V. Pinchuk
Irina V. Pinchuk
Tammara L. Watts
author_facet Jia Wang
Ruwen Cui
Cecila G. Clement
Ranjana Nawgiri
Don W. Powell
Irina V. Pinchuk
Irina V. Pinchuk
Tammara L. Watts
author_sort Jia Wang
collection DOAJ
description Desmoplasia, a hallmark of a head and neck cancer, has both biologic and physiologic effects on cancer progression and chemotherapeutic response. Mesenchymal stem/stromal cells (MSCs), also known as mesenchymal stromal progenitor cells, have been shown to play a role in cancer progression, alter apoptotic responses, and confer resistance to chemotherapy in various carcinomas. The pathophysiology of MSCs with respect to tumorigenesis is widely reported in other cancers and is sparsely reported in oral squamous cell carcinomas (OSCCs). We previously reported paracrine mediated PDGF-AA/PDGFR-α signaling to underlie MSCs chemotaxis in OSCC. Given the poor clinical response to primary chemotherapy, we hypothesized that MSCs may alter cancer cell sensitivity to cisplatin through activation of PDGFR-α mediated signaling pathways. Co-culture of MSCs with human derived OSCC cell lines, JHU-012 and −019, resulted in a significant increase in the production of PDGF-AA and MCP-1 compared to cancer cells grown alone (p < 0.005) and was accompanied by an increase in the phosphorylation state of PDGFR-α (p < 0.02) and downstream target AKT at S473 (p < 0.025) and T308 (p < 0.02). JHU-012 and −019 cancer cells grown in co-culture were significantly less apoptotic (p < 0.001), expressed significantly higher levels of Bcl-2 (p < 0.04) with a concomitant significant decrease in bid expression (p < 0.001) compared to cancer cells grown alone. There was a significant increase in the cisplatin dose response curve in cancer cell clones derived from JHU-012 and 019 cancer cells grown in co-culture with MSCs compared to clones derived from cancer cells grown alone (p < 0.001). Moreover clones derived from JHU-012 cells grown in co-culture with MSCs were significantly more susceptible to cisplatin following pretreatment with, crenolanib, a PDGFR inhibitor, compared to cancer cells grown alone or in co-culture with MSCs (p < 0.0001). These findings suggest that crosstalk between cancer cells and MSCs is mediated, at least in part, by activation of autocrine PDGF-AA/PDGFR-α loop driving AKT-mediated signaling pathways, resulting in reduced cancer cell sensitivity to cisplatin through alterations in apoptosis.
first_indexed 2024-12-11T18:49:44Z
format Article
id doaj.art-92d11a8b70f64a7c93915ceac3a354fd
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-11T18:49:44Z
publishDate 2020-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-92d11a8b70f64a7c93915ceac3a354fd2022-12-22T00:54:20ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-04-011010.3389/fonc.2020.00552503283Activation PDGFR-α/AKT Mediated Signaling Pathways in Oral Squamous Cell Carcinoma by Mesenchymal Stem/Stromal Cells Promotes Anti-apoptosis and Decreased Sensitivity to CisplatinJia Wang0Ruwen Cui1Cecila G. Clement2Ranjana Nawgiri3Don W. Powell4Irina V. Pinchuk5Irina V. Pinchuk6Tammara L. Watts7Department of Otolaryngology, University of Texas Medical Branch, Galveston, TX, United StatesDepartment of Otolaryngology, University of Texas Medical Branch, Galveston, TX, United StatesDepartment of Pathology, University of Texas Medical Branch, Galveston, TX, United StatesDepartment of Pathology, University of Texas Medical Branch, Galveston, TX, United StatesDepartment of Internal Medicine, Division of Gastroenterology, University of Texas Medical Branch, Galveston, TX, United StatesDepartment of Internal Medicine, Division of Gastroenterology, University of Texas Medical Branch, Galveston, TX, United StatesDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United StatesDepartment of Otolaryngology, University of Texas Medical Branch, Galveston, TX, United StatesDesmoplasia, a hallmark of a head and neck cancer, has both biologic and physiologic effects on cancer progression and chemotherapeutic response. Mesenchymal stem/stromal cells (MSCs), also known as mesenchymal stromal progenitor cells, have been shown to play a role in cancer progression, alter apoptotic responses, and confer resistance to chemotherapy in various carcinomas. The pathophysiology of MSCs with respect to tumorigenesis is widely reported in other cancers and is sparsely reported in oral squamous cell carcinomas (OSCCs). We previously reported paracrine mediated PDGF-AA/PDGFR-α signaling to underlie MSCs chemotaxis in OSCC. Given the poor clinical response to primary chemotherapy, we hypothesized that MSCs may alter cancer cell sensitivity to cisplatin through activation of PDGFR-α mediated signaling pathways. Co-culture of MSCs with human derived OSCC cell lines, JHU-012 and −019, resulted in a significant increase in the production of PDGF-AA and MCP-1 compared to cancer cells grown alone (p < 0.005) and was accompanied by an increase in the phosphorylation state of PDGFR-α (p < 0.02) and downstream target AKT at S473 (p < 0.025) and T308 (p < 0.02). JHU-012 and −019 cancer cells grown in co-culture were significantly less apoptotic (p < 0.001), expressed significantly higher levels of Bcl-2 (p < 0.04) with a concomitant significant decrease in bid expression (p < 0.001) compared to cancer cells grown alone. There was a significant increase in the cisplatin dose response curve in cancer cell clones derived from JHU-012 and 019 cancer cells grown in co-culture with MSCs compared to clones derived from cancer cells grown alone (p < 0.001). Moreover clones derived from JHU-012 cells grown in co-culture with MSCs were significantly more susceptible to cisplatin following pretreatment with, crenolanib, a PDGFR inhibitor, compared to cancer cells grown alone or in co-culture with MSCs (p < 0.0001). These findings suggest that crosstalk between cancer cells and MSCs is mediated, at least in part, by activation of autocrine PDGF-AA/PDGFR-α loop driving AKT-mediated signaling pathways, resulting in reduced cancer cell sensitivity to cisplatin through alterations in apoptosis.https://www.frontiersin.org/article/10.3389/fonc.2020.00552/fullPDGFR-αAKToral cancercrenolanibapoptosismesenchymal stem cells
spellingShingle Jia Wang
Ruwen Cui
Cecila G. Clement
Ranjana Nawgiri
Don W. Powell
Irina V. Pinchuk
Irina V. Pinchuk
Tammara L. Watts
Activation PDGFR-α/AKT Mediated Signaling Pathways in Oral Squamous Cell Carcinoma by Mesenchymal Stem/Stromal Cells Promotes Anti-apoptosis and Decreased Sensitivity to Cisplatin
Frontiers in Oncology
PDGFR-α
AKT
oral cancer
crenolanib
apoptosis
mesenchymal stem cells
title Activation PDGFR-α/AKT Mediated Signaling Pathways in Oral Squamous Cell Carcinoma by Mesenchymal Stem/Stromal Cells Promotes Anti-apoptosis and Decreased Sensitivity to Cisplatin
title_full Activation PDGFR-α/AKT Mediated Signaling Pathways in Oral Squamous Cell Carcinoma by Mesenchymal Stem/Stromal Cells Promotes Anti-apoptosis and Decreased Sensitivity to Cisplatin
title_fullStr Activation PDGFR-α/AKT Mediated Signaling Pathways in Oral Squamous Cell Carcinoma by Mesenchymal Stem/Stromal Cells Promotes Anti-apoptosis and Decreased Sensitivity to Cisplatin
title_full_unstemmed Activation PDGFR-α/AKT Mediated Signaling Pathways in Oral Squamous Cell Carcinoma by Mesenchymal Stem/Stromal Cells Promotes Anti-apoptosis and Decreased Sensitivity to Cisplatin
title_short Activation PDGFR-α/AKT Mediated Signaling Pathways in Oral Squamous Cell Carcinoma by Mesenchymal Stem/Stromal Cells Promotes Anti-apoptosis and Decreased Sensitivity to Cisplatin
title_sort activation pdgfr α akt mediated signaling pathways in oral squamous cell carcinoma by mesenchymal stem stromal cells promotes anti apoptosis and decreased sensitivity to cisplatin
topic PDGFR-α
AKT
oral cancer
crenolanib
apoptosis
mesenchymal stem cells
url https://www.frontiersin.org/article/10.3389/fonc.2020.00552/full
work_keys_str_mv AT jiawang activationpdgfraaktmediatedsignalingpathwaysinoralsquamouscellcarcinomabymesenchymalstemstromalcellspromotesantiapoptosisanddecreasedsensitivitytocisplatin
AT ruwencui activationpdgfraaktmediatedsignalingpathwaysinoralsquamouscellcarcinomabymesenchymalstemstromalcellspromotesantiapoptosisanddecreasedsensitivitytocisplatin
AT cecilagclement activationpdgfraaktmediatedsignalingpathwaysinoralsquamouscellcarcinomabymesenchymalstemstromalcellspromotesantiapoptosisanddecreasedsensitivitytocisplatin
AT ranjananawgiri activationpdgfraaktmediatedsignalingpathwaysinoralsquamouscellcarcinomabymesenchymalstemstromalcellspromotesantiapoptosisanddecreasedsensitivitytocisplatin
AT donwpowell activationpdgfraaktmediatedsignalingpathwaysinoralsquamouscellcarcinomabymesenchymalstemstromalcellspromotesantiapoptosisanddecreasedsensitivitytocisplatin
AT irinavpinchuk activationpdgfraaktmediatedsignalingpathwaysinoralsquamouscellcarcinomabymesenchymalstemstromalcellspromotesantiapoptosisanddecreasedsensitivitytocisplatin
AT irinavpinchuk activationpdgfraaktmediatedsignalingpathwaysinoralsquamouscellcarcinomabymesenchymalstemstromalcellspromotesantiapoptosisanddecreasedsensitivitytocisplatin
AT tammaralwatts activationpdgfraaktmediatedsignalingpathwaysinoralsquamouscellcarcinomabymesenchymalstemstromalcellspromotesantiapoptosisanddecreasedsensitivitytocisplatin